Price reduction of drugs after loss of exclusivity in the U.S. 2015
This statistic represents the monthly price reduction of medicines after their loss of exclusivity in the United States, as of 2015. After 12 months of patent loss, oral drugs suffered a price reduction of some 66 percent.